RoboCT Exoskeleton Technologies for Rehabilitation and Elderly Care
The global aging population and an increasing number of individuals with mobility impairments due to neurological damage have created a rising demand for rehabilitation and elder care solutions. RoboCT addresses this by developing advanced exoskeleton technology that assists individuals with motor dysfunction and mobility impairments, providing solutions that improve human mobility and rehabilitation outcomes. These technologies are designed to integrate seamlessly into medical facilities and personal care, improving the quality of life for users and enhancing their independence.
Biotechnology And National Health
Technologies for human health
The typical implementation of RoboCT’s exoskeleton solutions in medical institutions takes around 6 to 12 months, from initial partnership to full integration into clinical practice.
RoboCT’s solutions have been implemented in hospitals and rehabilitation centers across China, with plans for expansion into international markets, including the broader Asian and European regions. The company’s products are currently in use in over 300 hospitals and rehabilitation institutions across China.
RoboCT stands out in the field due to its focus on the development of core algorithms and components for exoskeleton technology. As the first Chinese company to obtain an NMPA registration certificate for exoskeletons focused on neurological rehabilitation, it has a competitive edge in technology development, intellectual property rights (over 450 independent patents), and international recognition (over 40 design awards). Its deep integration with over 300 top domestic hospitals and rehabilitation centers provides an unparalleled advantage in terms of clinical validation and user feedback.
N.A.
N.A.
